ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,502, issued on Sept. 23, was assigned to TILT BIOTHERAPEUTICS OY (Helsinki).
"Enhanced adoptive cell therapy" was invented by Akseli Hemminki (Helsinki), Markus Vaha-Koskela (Helsinki), Siri Tahtinen (Helsinki) and Vincenzo Cerullo (Helsinki).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is disclosed oncolytic adenoviral vectors alone or together with therapeutic compositions for therapeutic uses and therapeutic methods for cancer. In one aspect, there is also disclosed the separate administration of adoptive cell therapeutic composition and oncolytic adenoviral vectors. Furthermore, there is disclosed a pharmaceutical kit and a pharmaceutica...